{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:10:23Z","timestamp":1778875823361,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009459","name":"Hvidovre Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R324-2019-1375"],"award-info":[{"award-number":["R324-2019-1375"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R303-2018-3396"],"award-info":[{"award-number":["R303-2018-3396"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R335-2019-20152"],"award-info":[{"award-number":["R335-2019-20152"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["0088618"],"award-info":[{"award-number":["0088618"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI168251"],"award-info":[{"award-number":["AI168251"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI158193"],"award-info":[{"award-number":["AI158193"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2025.101684","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:36:55Z","timestamp":1763635015000},"page":"101684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vivo Determinants of Hepatitis C Virus Adaptation and Escape From Neutralizing Antibody AR5A"],"prefix":"10.1016","volume":"20","author":[{"given":"Rodrigo","family":"Vel\u00e1zquez-Moctezuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani","family":"Burm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Verhoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenn","family":"Holmbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Giang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansun","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-9478","authenticated-orcid":false,"given":"Jannick","family":"Prentoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2025.101684_bib1","unstructured":"World Health Organization. Hepatitis C. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Accessed April 1, 2025."},{"key":"10.1016\/j.jcmgh.2025.101684_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","article-title":"The history of hepatitis C virus (HCV): basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","volume":"65","author":"Bukh","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2025.101684_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13027-016-0071-z","article-title":"Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States","volume":"11","author":"Rosenthal","year":"2016","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.jcmgh.2025.101684_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV virus taxonomy profile: flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib6","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2025.101684_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.510250530","article-title":"Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus","volume":"25","author":"Zibert","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007772","article-title":"Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design Rey FA","volume":"15","author":"Keck","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib11","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1128\/JVI.01194-15","article-title":"Immunoglobulin with high-titer in vitro cross-neutralizing hepatitis C virus antibodies passively protects chimpanzees from homologous, but not heterologous, challenge","volume":"89","author":"Bukh","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus","volume":"53","author":"Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib13","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver\u2013chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41586-024-07783-5","article-title":"The hepatitis C virus envelope protein complex is a dimer of heterodimers","volume":"633","author":"Augestad","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2025.101684_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2025.101684_bib16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by thehepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2025.101684_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2013.05.007","article-title":"Neutralizing antibodies induced by cell culture\u2013derived hepatitis C virus protect against infection in mice","volume":"145","author":"Akazawa","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib18","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1038\/s41598-018-24762-9","article-title":"Immunological responses following administration of a genotype 1a\/1b\/2\/3a quadrivalent HCV VLP vaccine","volume":"8","author":"Christiansen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2025.101684_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2018.03.026","article-title":"Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice","volume":"519","author":"Krapchev","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036947","article-title":"Challenges and promise of a hepatitis C virus vaccine","volume":"10","author":"Cox","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcmgh.2025.101684_bib21","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.0902749106","article-title":"Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2025.101684_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2025.101684_bib23","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2025.101684_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002653","article-title":"Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate","volume":"8","author":"Keck","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004297","article-title":"Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412\u2013423","volume":"10","author":"Keck","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib26","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1128\/JVI.78.17.9224-9232.2004","article-title":"Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions","volume":"78","author":"Keck","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib27","doi-asserted-by":"crossref","first-page":"19450","DOI":"10.1073\/pnas.0809879105","article-title":"In vitro selection of a neutralization-resistant hepatitis C virus escape mutant","volume":"105","author":"Gal-Tanamy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2025.101684_bib28","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1128\/JVI.05259-11","article-title":"Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations","volume":"85","author":"Keck","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib29","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jmb.2013.02.025","article-title":"Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies","volume":"425","author":"Pantua","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib30","doi-asserted-by":"crossref","first-page":"e02066","DOI":"10.1128\/JVI.02066-17","article-title":"Escape of hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes","volume":"92","author":"Gu","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib31","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1016\/j.vaccine.2010.04.024","article-title":"Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies","volume":"28","author":"Duan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jcmgh.2025.101684_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/ajt.12083","article-title":"Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study","volume":"13","author":"Chung","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcmgh.2025.101684_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100325","article-title":"High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody","volume":"9","author":"Babcock","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2025.101684_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/vaccines9030291","article-title":"Mechanisms of hepatitis C virus escape from vaccine-relevant neutralizing antibodies","volume":"9","author":"Vel\u00e1zquez-Moctezuma","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jcmgh.2025.101684_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.antiviral.2018.07.014","article-title":"Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: essential tools in testing of antivirals and emerging vaccine strategies","volume":"158","author":"Ramirez","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2025.101684_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006214","article-title":"Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A","volume":"13","author":"Vel\u00e1zquez-Moctezuma","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/infdis\/jiy481","article-title":"Hepatitis C virus\u2013escape studies for human monoclonal antibody AR4A reveal isolate-specific resistance and a high barrier to resistance","volume":"219","author":"Vel\u00e1zquez-Moctezuma","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcmgh.2025.101684_bib38","doi-asserted-by":"crossref","first-page":"e01909","DOI":"10.1128\/JVI.01909-18","article-title":"Hepatitis C virus escape studies of human antibody AR3A reveal a high barrier to resistance and novel insights on viral antibody evasion mechanisms","volume":"93","author":"Vel\u00e1zquez-Moctezuma","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fimmu.2018.01032","article-title":"Animal models to study hepatitis C virus infection","volume":"9","author":"Burm","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105843","article-title":"Preclinical animal models to evaluate therapeutic antiviral antibodies","volume":"225","author":"De Meyer","year":"2024","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2025.101684_bib41","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1136\/gutjnl-2015-310300","article-title":"HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice","volume":"65","author":"Prentoe","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2025.101684_bib42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/hep.28428","article-title":"Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge","volume":"63","author":"Desombere","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2017.10.015","article-title":"A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo","volume":"148","author":"Desombere","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2025.101684_bib44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/HEP.0000000000000897","article-title":"JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: important tools in the evaluation of virus neutralization","volume":"80","author":"Collignon","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib45","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1073\/pnas.1822002116","article-title":"Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations","volume":"116","author":"Prentoe","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2025.101684_bib46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fimmu.2018.00910","article-title":"Glycan shielding and modulation of hepatitis C virus neutralizing antibodies","volume":"9","author":"Lavie","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.32772","article-title":"Identification of novel neutralizing determinants for protection against HCV","volume":"77","author":"Alzua","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib48","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1099\/vir.0.010983-0","article-title":"Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells","volume":"90","author":"Bungyoku","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib49","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"Prentoe","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006235","article-title":"Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1","volume":"13","author":"El-Diwany","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib51","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/JVI.02017-13","article-title":"Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus","volume":"88","author":"Prentoe","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5938","article-title":"Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity","volume":"6","author":"Augestad","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcmgh.2025.101684_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009720","article-title":"In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus","volume":"17","author":"Olesen","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2025.101684_bib54","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/JVI.02837-15","article-title":"A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies","volume":"90","author":"Wasilewski","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.chom.2018.10.012","article-title":"Broadly neutralizing antibody mediated clearance of human hepatitis C virus infection","volume":"24","author":"Kinchen","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2025.101684_bib56","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1128\/JVI.01011-16","article-title":"A library of infectious hepatitis C viruses with engineered mutations in the E2 gene reveals growth-adaptive mutations that modulate interactions with scavenger receptor class B type I","volume":"90","author":"Zuiani","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2012.02.018","article-title":"Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice","volume":"57","author":"Lacek","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib58","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/hep.27196","article-title":"Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents","volume":"60","author":"Vercauteren","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib59","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/gutjnl-2014-309045","article-title":"Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice","volume":"65","author":"Vercauteren","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2025.101684_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcmgh.2025.101684_bib61","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2010.05.077","article-title":"Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins","volume":"139","author":"Dahari","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib62","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal models for the study of hepatitis C virus infection and related liver disease","volume":"142","author":"Bukh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib63","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2025.101684_bib64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2025.101684_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/hv.34306","article-title":"Hepatitis B vaccination","volume":"11","author":"Roman\u00f2","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jcmgh.2025.101684_bib66","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/jvh.13525","article-title":"Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations","volume":"28","author":"Mokaya","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jcmgh.2025.101684_bib67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2025.101684_bib68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.24692","article-title":"A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo","volume":"55","author":"Meuleman","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib69","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib70","first-page":"433","article-title":"In vitro neutralization assay using cultured hepatitis C virus","author":"Prentoe","year":"2019","journal-title":"Mehtods Mol Biol"},{"key":"10.1016\/j.jcmgh.2025.101684_bib71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2025.101684_bib72","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0006-291X(03)01388-3","article-title":"A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice","volume":"308","author":"Meuleman","year":"2003","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X25002255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X25002255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:29:21Z","timestamp":1778873361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X25002255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X25002255"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101684","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Determinants of Hepatitis C Virus Adaptation and Escape From Neutralizing Antibody AR5A","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"101684"}}